PATENT CLAIM ANALYSIS

Application Number: 16179605
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "501000"]

Abstract:
Compositions and methods for efficient delivery of therapeutic agents in vivo are provided. Typically, the compositions are in the form of polymeric particles formed from one or more therapeutic agent complexed with a polycationic polymer which is further encapsulated in one or more amphiphilic polymers, preferably diblock copolymer of a polyalkylene oxide and a polyester such as poly(D,L-lactide)-poly(ethylene glycol) (PLA-PEG). In the preferred embodiments, the chemotherapeutic agent reduces, or inhibits N-glycosylation of one or more receptor tyrosine kinases of cancer cells. Methods of using the particles to treat cancer are also provided.

Claim (Index 11):
The particles of  claim 10 , wherein the receptor tyrosine kinase is one or more EGFR family members, FGFR family members, or combinations thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.54167
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14907539', '14293733', '14956585', '15488116', '14206223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7310286651832457
- 35 USC 102 Novelty (BERT): 0.4992214538951464
- Combined Prediction Score: 0.7078479440544359
- Mean Citation Score: 220.60627400000004
- Max Citation Score: 235.5712
- Similarity Product: 166.67745926513672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test